The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators
dc.contributor.author | Benchekroun, Mohamed | |
dc.contributor.author | Romero Hernández, Alejandro | |
dc.contributor.author | Egea, Javier | |
dc.contributor.author | León Martínez, Rafael | |
dc.contributor.author | Michalska Dziama, Patrycja | |
dc.contributor.author | Buendía, Izaskun | |
dc.contributor.author | Jimeno, María Luisa | |
dc.contributor.author | Jun, Daniel | |
dc.contributor.author | Janockova, Jana | |
dc.contributor.author | Sepsova, Vendula | |
dc.contributor.author | Soukup, Ondrej | |
dc.contributor.author | Bautista-Aguilera, Oscar | |
dc.contributor.author | Refouvelet, Bernard | |
dc.contributor.author | Ouari, Olivier | |
dc.contributor.author | Marco Contelles, José Luis | |
dc.contributor.author | Ismaili, Lhassane | |
dc.date.accessioned | 2024-01-31T12:44:37Z | |
dc.date.available | 2024-01-31T12:44:37Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Novel multifunctional tacrines for Alzheimer’s disease were obtained by Ugi-reaction between ferulic (or lipoic acid), a melatonin-like isocyanide, formaldehyde, and tacrine derivatives, according to the antioxidant additive approach in order to modulate the oxidative stress as therapeutic strategy. Compound 5c has been identified as a promising permeable agent showing excellent antioxidant properties, strong cholinesterase inhibitory activity, less hepatotoxicity than tacrine, and the best neuroprotective capacity, being able to significantly activate the Nrf2 transcriptional pathway. | |
dc.description.department | Depto. de Química en Ciencias Farmacéuticas | |
dc.description.faculty | Fac. de Farmacia | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Conseil régional de Franche-Comté (France) | |
dc.description.sponsorship | Instituto de Salud Carlos III | |
dc.description.sponsorship | Faculty of Military Health Sciences, University of Defence (Czech Republic) | |
dc.description.sponsorship | Bayer AG | |
dc.description.sponsorship | Fundación FIPSE | |
dc.description.sponsorship | Ministerio de Educación, Cultura y Deporte (España) | |
dc.description.status | pub | |
dc.identifier.citation | Benchekroun, Mohamed, et al. «The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators». Journal of Medicinal Chemistry, vol. 59, n.o 21, noviembre de 2016, pp. 9967-73. https://doi.org/10.1021/acs.jmedchem.6b01178. | |
dc.identifier.doi | 10.1021/acs.jmedchem.6b01178 | |
dc.identifier.issn | 0022-2623 | |
dc.identifier.officialurl | https://doi.org/10.1021/acs.jmedchem.6b01178 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/97148 | |
dc.issue.number | 21 | |
dc.journal.title | Journal of Medicinal Chemistry | |
dc.language.iso | eng | |
dc.page.final | 9973 | |
dc.page.initial | 9967 | |
dc.relation.projectID | info:eu-repo/grantAgreement/CP14/00008 | |
dc.relation.projectID | info:eu-repo/grantAgreement/00179906 | |
dc.relation.projectID | info:eu-repo/grantAgreement/PI14/00372 | |
dc.relation.projectID | info:eu-repo/grantAgreement/2015-03-1282 | |
dc.relation.projectID | info:eu-repo/grantAgreement/12-00001344-15 | |
dc.relation.projectID | info:eu-repo/grantAgreement/FPU13/03737 | |
dc.rights.accessRights | restricted access | |
dc.subject.keyword | Multitarget ligand | |
dc.subject.keyword | Nrf2 pathway | |
dc.subject.keyword | Alzheimer´s disease | |
dc.subject.keyword | Drug discovery | |
dc.subject.ucm | Ciencias Biomédicas | |
dc.subject.unesco | 23 Química | |
dc.title | The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 59 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 32828fad-26cb-4919-a993-8cb836db4ad4 | |
relation.isAuthorOfPublication | 7093c6ce-e368-44f0-a993-8f7212cb1c2a | |
relation.isAuthorOfPublication | 298927e3-bd5b-46ad-bdbe-b818ade8cfb1 | |
relation.isAuthorOfPublication | 20877297-0870-49ef-a0fb-9fc4cba06794 | |
relation.isAuthorOfPublication.latestForDiscovery | 7093c6ce-e368-44f0-a993-8f7212cb1c2a |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Antioxidant_Additive_Approach.pdf
- Size:
- 740.28 KB
- Format:
- Adobe Portable Document Format